Trexquant Investment LP Praxis Precision Medicines, Inc. Transaction History

Trexquant Investment LP

  • $7.59 Billion
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2022

Aug 11, 2022
SELL
$1.75 - $11.34 $49,084 - $318,064
-28,048 Closed
0 $0
Q1 2022

May 13, 2022
BUY
$10.21 - $20.29 $123,153 - $244,737
12,062 Added 75.45%
28,048 $286,000
Q4 2021

Feb 14, 2022
BUY
$16.76 - $22.99 $267,925 - $367,518
15,986 New
15,986 $315,000

Others Institutions Holding PRAX

# of Institutions
1
Shares Held
75K
Call Options Held
0
Put Options Held
0
View Full List

About Praxis Precision Medicines, Inc.

PRAX Quotes by TradingView
  • Ticker PRAX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 45,576,100
  • Market Cap $3.54B
  • Description
  • Praxis Precision Medicines, Inc., a clinical-stage biopharmaceutical company, develops therapies for central nervous system disorders characterized by neuronal imbalance. Its lead product candidates include PRAX-114, an extrasynaptic-preferring GABAA receptor positive allosteric modulator that is in Phase IIa clinical trial for the treatment of ...
More about PRAX
Track This Portfolio

Track Trexquant Investment LP Portfolio

Follow Trexquant Investment LP and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Trexquant Investment LP, based on Form 13F filings with the SEC.

News

Stay updated on Trexquant Investment LP with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email